There is a multitude of events that could be announced at any given time. Long investors know them well. For me, this only centers around RecoveryRx. We have not heard a peep from anybody apart from a brief mention in the last pr and even that was in reference to overseas (non-usa) distributorships. I can't shake the feeling something big is in the works in re: to RecoveryRx.
The reasoning for its use, either in terms of financials, healthcare outcomes, or opioid related is beyond compelling. It is simply the right thing to do. I also know from my own dd that the bar to being accepted into CMMS, HCPCS or DOD registries to become eligible for insurance reimbursement, is that the device or procedure is "reasonable & necessary".
Understanding RecoveryRx is "reasonable & necessary" is a no brainer. Going thru the process is another matter altogether involving reams and reams, thousands of pages of rules, regulations, policies, involving multiple parties, resubmissions, teams of lawyers & accountants, etc. But ... if we were to license RecoveryRx to someone who has already done this for other products in their own corporate basket then we have a different ballgame. Oh, If only I could wave a magic wand !
Insofar as the TENS unit is concerned, as of 2012 Medicare no longer gave a blanket coverage for it. It can still be covered but the condition has to be specific, post-op, etc. Its a real pain trying to figure it all out. Masses of bureaucratic bs to wade thru. I suspect the same is true for Tri-Care (military) and private insurance.
So, at some point in time somebody somewhere thought TENS was "reasonable & necessary". All I can say is ... you can fool some of the people some of the time but ... I am waiting to be pleasantly surprised re: RecoveryRx.
DJO - for the past 2 yrs they have been on a shopping spree to the tune of about $1.2 billion. Check them out and then try thinking about how they might incorporate Actipatch into those asset acquisitions. These guys are gearing up. They also own Dr. Comfort, a competitor to Dr. Scholl's.
https://www.djoglobal.com/investors/press-rel...t-surgical
that's it, nuthin' much - later - WBeacham
The reasoning for its use, either in terms of financials, healthcare outcomes, or opioid related is beyond compelling. It is simply the right thing to do. I also know from my own dd that the bar to being accepted into CMMS, HCPCS or DOD registries to become eligible for insurance reimbursement, is that the device or procedure is "reasonable & necessary".
Understanding RecoveryRx is "reasonable & necessary" is a no brainer. Going thru the process is another matter altogether involving reams and reams, thousands of pages of rules, regulations, policies, involving multiple parties, resubmissions, teams of lawyers & accountants, etc. But ... if we were to license RecoveryRx to someone who has already done this for other products in their own corporate basket then we have a different ballgame. Oh, If only I could wave a magic wand !
Insofar as the TENS unit is concerned, as of 2012 Medicare no longer gave a blanket coverage for it. It can still be covered but the condition has to be specific, post-op, etc. Its a real pain trying to figure it all out. Masses of bureaucratic bs to wade thru. I suspect the same is true for Tri-Care (military) and private insurance.
So, at some point in time somebody somewhere thought TENS was "reasonable & necessary". All I can say is ... you can fool some of the people some of the time but ... I am waiting to be pleasantly surprised re: RecoveryRx.
DJO - for the past 2 yrs they have been on a shopping spree to the tune of about $1.2 billion. Check them out and then try thinking about how they might incorporate Actipatch into those asset acquisitions. These guys are gearing up. They also own Dr. Comfort, a competitor to Dr. Scholl's.
https://www.djoglobal.com/investors/press-rel...t-surgical
that's it, nuthin' much - later - WBeacham
2
1
